bullish
MIRA: IND Application Submitted to FDA
MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report
What is covered in the Full Insight:
- Introduction to MIRA Pharmaceuticals
- IND Application and Phase 1 Trials
- Preclinical Study Results for Ketamir-2
- Comparative Analysis with Existing Treatments
- Investment Outlook and Recommendations
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
x